Screening compound: CTIPIFDAICSKJJ-UHFFFAOYSA-N

Screening compound: CTIPIFDAICSKJJ-UHFFFAOYSA-N
Screening compound: CTIPIFDAICSKJJ-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
CTIPIFDAICSKJJ-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J030-0465

Molecular Formula

C21H23N3O4S (C21 H23 N3 O4 S)

Compound Name

3-(1-pyrrolidinyl)-2-(1-pyrrolidinylsulfonyl)dibenzo[b,f][1,4]oxazepin-11(10H)-one

IUPAC name

14-(pyrrolidin-1-yl)-13-(pyrrolidine-1-sulfonyl)-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(15)3571113-hexaen-10-one

SMILES

O=C(c1c2)Nc(cccc3)c3Oc1cc(N1CCCC1)c2S(N1CCCC1)(=O)=O

InChI

InChI=1S/C21H23N3O4S/c25-21-15-13-20(29(26,27)24-11-5-6-12-24)17(23-9-3-4-10-23)14-19(15)28-18-8-2-1-7-16(18)22-21/h1-2,7-8,13-14H,3-6,9-12H2,(H,22,25)

InChI Key

CTIPIFDAICSKJJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27220227

CTIPIFDAICSKJJ-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

KRAS-Targeted Library (16000 compounds)

Nucleic Acid Ligands (8311 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with CTIPIFDAICSKJJ-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound CTIPIFDAICSKJJ-UHFFFAOYSA-N?
Check Price and Availability of CTIPIFDAICSKJJ-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of CTIPIFDAICSKJJ-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for CTIPIFDAICSKJJ-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for CTIPIFDAICSKJJ-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of CTIPIFDAICSKJJ-UHFFFAOYSA-N available by request